Table 1. Characteristics of the whole study population, and stratified by duration of diabetes in years.

	All N = 13771	0–5 Years N = 8003	5–10 Years N = 5219	≥ 10 Years N = 549	p-value
Sex (Female)	9246 (67.2%)	5225 (65.4%)	3635 (69.7%)	386 (70.4%)	<0.001
Age at diabetes ascertainment (Years)	52.0 [44.0;59.0]	52.0 [44.0;61.0]	51.0 [44.0;58.0]	50.0 [42.0;57.0]	<0.001
Baseline HbA1c (%) a	8.5 [7.0;11.1]	7.9 [6.8;10.5]	9.5 [7.6;11.8]	9.9 [8.3;11.5]	<0.001
Last HbA1c (%)	9.5 [7.2;12.7]	8.6 [6.8;12.4]	10.3 [8.0;13.1]	10.8 [8.6;13.2]	<0.001
Patient outcome (Deceased)	631 (4.6%)	377 (4.7%)	237 (4.5%)	17 (3.1%)	0.213
Diabetes duration since ascertainment (Years)	4.1 [1.2;6.5]	1.6 [0.1;3.3]	6.6 [5.9;7.8]	10.7 [10.3;11.2]	0.000
Ever started diabetes treatment	11745 (85.3%)	6012 (75.1%)	5186 (99.4%)	547 (99.6%)	0.000
Ever had Tuberculosis	1839 (13.4%)	910 (11.4%)	831 (15.9%)	98 (17.9%)	<0.001
TB-Diabetes comorbidity b	1008 (55.9%)	372 (41.9%)	547 (67.0%)	89 (91.8%)	<0.001
HIV Positive	2508 (18.2%)	1478 (18.5%)	932 (17.9%)	98 (17.9%)	0.657

a. Baseline HbA1c was defined as the first recorded HbA1c value either at diabetes ascertainment or within the first year after diabetes ascertainment

b. Proportions calculated from those who had ever had Tuberculosis